Cleared Traditional

K212431 - Biomet Answer/Impact/Integral Distal Centralizer/Centering Sleeve

K212431 is an FDA 510(k) clearance for Biomet Answer/Impact/Integral Distal Ce..., manufactured by Biomet, Inc.. The device is a Class 2 Orthopedic device with product code JDG cleared through the Traditional 510(k) pathway after a 187-day FDA review.

K212431 · Biomet, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
187d
Days
Class 2
Risk

K212431 is an FDA 510(k) clearance for the Biomet Answer/Impact/Integral Distal Centralizer/Centering Sleeve. Classified as Prosthesis, Hip, Femoral Component, Cemented, Metal (product code JDG), Class II - Special Controls.

Submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on February 7, 2022 after a review of 187 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3360 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biomet, Inc. devices

FDA 510(k) Submission Details - K212431

510(k) Number K212431 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2021
Decision Date February 07, 2022
Days to Decision 187 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d slower than avg
Panel avg: 122d · This submission: 187d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JDG Device Classification - Class 2, Special Controls

Product Code JDG Prosthesis, Hip, Femoral Component, Cemented, Metal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - JDG Prosthesis, Hip, Femoral Component, Cemented, Metal

All 47
Devices cleared under the same product code (JDG) and FDA review panel - the closest regulatory comparables to K212431.
Distal Centralizers
K193546 · Biomet, Inc. · Sep 2020
Exeter V40 Femoral Stem Hip System, Orthinox V40 Femoral Heads
K173499 · Stryker Orthopaedics · Mar 2018
PROGENY FORGED COCR CEMENTED FEMORAL COMPONENT
K001984 · Stelkast Company · Sep 2000
THE TAPER-FIT TOTAL HIP SYSTEM
K992234 · Corin USA · Nov 1999
AURA HIP SYSTEM CALCAR REPLACEMENT FEMORAL STEM
K962002 · Exactech, Inc. · Aug 1996
NEXLOCK FEMORAL STEM
K955171 · Nexmed, Inc. · Feb 1996